Authors
Latest:
Follow the Money... Where Healthcare Policy is HeadedCMS will be changing reimbursement practices regardless of how healthcare reform plays out
Latest:
Pharma pricing and antitrust lawUS courts fail to clarify when pricing may violate antitrust laws
Latest:
The Evolving Retail Pharmacy Channel: Implications for ManufacturersAggressive cost competition and the continuing growth of generic substitution will separate retailers’ interests from manufacturers’
Latest:
Air Cargo Logistics: Critical Collaboration Points, Sustainability and Thermal PackagingAlison Crawley and Bourji Mourad, Sonoco ThermoSafe, react to lessons learned from the 2024 LogiPharma Masterclass and consider the future of sustainable thermal packaging as it relates to air cargo logistics.
Latest:
Specialty Pharmaceuticals and the Emergence of Sub-Specialty Pharmacy‘Ultra-orphan’ diseases will alter the specialty distribution process
Latest:
Drug shortages are opening the door to price gougingHospital pharmacies need to be vigilant in ensuring safe supplies of scarce drugs
Latest:
Is tech running you? Four ways to retake controlModern training technologies make the prospect of days-long training courses an obsolete practice
Latest:
The clear and present danger of counterfeit drugsProspects for international policing of counterfeit drugs is dim
Latest:
Industry should reinforce cargo security practices with TAPA participationUltimately, supply chain integrity should include both temperature control and security against theft or diversion
Latest:
The right supply chain prescriptionWhile pharma manufacturers may be concerned about the impact of item-level inventory tracking, it's an idea that actually makes great business sense
Latest:
The convergence of international and US pricing controlsNew approaches, and new skill sets are necessary for meeting the challenges of global drug reimbursement policies
Latest:
Common misconceptions about the orphan drug designationThings to know about the increasingly popular--and competitive--orphan drug space
Latest:
Building an Alternative Distribution Model for Ultra-Orphan DiseasesBiopharmaceutical manufacturers turn to a direct-distribution model to leverage opportunities for cost-effective drug delivery and personalized health management services
Latest:
Rare disease patient supportRare diseases are hard to treat; supporting the patient can be even more challenging
Latest:
Data as a strategic asset in the life sciencesBuilding in the right processes and support for data quality, standards, and governance
Latest:
A Roadmap to Optimizing Marketing OperationsUnifying a company’s approach to marketing fulfillment activities could provide innovation while delivering cost savings
Latest:
A New Business Model for Pharma InnovationThe studio model: how film industry practices can boost pharmaceutical creativity
Latest:
ACOs raise the stakes for evidence-based medicineManufacturers will need to refine their interactions with healthcare providers and produce better outcomes research and adherence programs to compete
Latest:
Is your corporate board equipped to monitor incentive programs?Compliance officers at pharma companies need to ensure that the right mechanisms are in place for monitoring sales and business incentives
Latest:
A New Business Model for Pharma InnovationThe studio model: how film industry practices can boost pharmaceutical creativity
Latest:
The potential of translational research for new medicinesThe proposed federal National Center for Advancing Translational Sciences holds promise for drug development
Latest:
Legal uncertainties in the DSCSAThe Drug Supply Chain Security Act creates uncertainty about which trading partners have responsibility for product verification
Latest:
Accelerating the drive toward patient centricityGetting away from the traditional product-centric management structure is not easy; here’s how to do it
Latest:
Medical-Claims Database Analysis of Off-Label PrescribingExamining off-label use of highly prescribed drugs reveals factors that differ from the usual criticism of such usage
Latest:
Organizing Your Commercial Compliance ProgramsRegulatory attention has intensified over commercial activities. Here’s what to do to minimize risks and raise compliance levels
Latest:
How to prepare a cold chain for looming COVID-19 demandsAgile approaches to averting vaccine wastage will be critical to global delivery ramp-up
Latest:
Include the sales force in incentive compensationBy working with the sales force, incentive plan design can boost a product launch
Latest:
Adopting the TAPA cargo security standards in the pharmaceutical industrySecuring your supply chain
Latest:
Supply chain issues for 2012Tompkins International's annual preview of key pharma supply chain issues
Latest:
Getting from multichannel marketing to customer-centric marketingToday's pharma marketers have the tools to refine their communication efforts to prescribers and patients
